2/26
03:33 pm
fate
Fate Therapeutics (FATE) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
Low
Report
Fate Therapeutics (FATE) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
2/26
09:35 am
fate
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates [Yahoo! Finance]
High
Report
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates [Yahoo! Finance]
2/26
09:00 am
fate
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Medium
Report
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
2/3
10:21 pm
fate
?????????????????????:2032???11750???????????? [CNET News]
Low
Report
?????????????????????:2032???11750???????????? [CNET News]
2/3
04:05 pm
fate
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
1/5
04:05 pm
fate
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Neutral
Report
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
12/21
09:44 am
fate
Companies Like Fate Therapeutics (NASDAQ:FATE) Could Be Quite Risky [Yahoo! Finance]
Low
Report
Companies Like Fate Therapeutics (NASDAQ:FATE) Could Be Quite Risky [Yahoo! Finance]
12/8
08:00 am
fate
Fate Therapeutics Presents Updated Phase 1 Clinical Data of FT819 Off-the-shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-the-Shelf CAR T-cell Programs
Low
Report
Fate Therapeutics Presents Updated Phase 1 Clinical Data of FT819 Off-the-shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-the-Shelf CAR T-cell Programs